NIPT. Screen for genetic disorders to best guide your fetus’s health.

NIPT Non-Invasive Prenatal Screening Package

NIPT Screen for genetic disorders to best guide your fetus’s health

Non-Invasive Prenatal Screening or NIPT is a non-invasive screening method used to determine the chromosomal abnormalities of the fetus using maternal blood when the gestational age reaches 10-20 weeks. 

• Screening for fetal risks of developing chromosomal anomalies
• Screening for certain chromosomes causing congenital disorders or disability 
• Reducing the need for unnecessary amniocentesis
• Guiding for a proper pregnancy care and planning

With Whole-Genome Next Generation Sequencing (NGS) technology, the results are highly reliable, precise and accurate with no associated risks for the mother and the fetus.